PLAINSBORO, N.J., Dec. 18, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today announced President and Chief Executive Officer Peter Arduini will speak at the 37 th Annual J.P.

Preliminary Fourth Quarter 2018 Highlights: Fourth quarter 2018 reported revenue is expected to be at the higher end of the company’s previous guidance range of $378 million to $383 million; Organic revenue growth in the fourth quarter 2018 is expected to be slightly above 4%.

PLAINSBORO, N.J., Jan. 08, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation  (Nasdaq: IART ), a leading global medical technology company, today announced it has signed a license and development agreement with Consortium of Focused Orthopedists, LLC (CFO), for a short stem and

PLAINSBORO, N.J., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation  (Nasdaq:IART), a leading global medical technology company, today announced the appointment of Rhonda Germany Ballintyn to its board of directors, effective today.  Ms.

PLAINSBORO, N.J. , Jan. 10, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation  (Nasdaq:IART), a leading global medical technology company, today announced the full market release of the Integra® Titan™ Reverse Shoulder System-S (RSS-S).  This launch includes a new glenoid baseplate

PLAINSBORO, N.J., Jan. 31, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release fourth quarter and full-year 2018 financial results on Thursday, February 21, 2019, prior to market open.

PLAINSBORO, N.J., Feb. 13, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced the launch of the Integra® Panta® 2 TTC Arthrodesis Nail System for tibio-talo-calcaneal (TTC) fusion of the ankle due to severe

Fourth Quarter 2018 reported revenue increased 4.0% to $383.3 million; organic revenue increased 4.4% Fourth Quarter 2018 GAAP earnings per diluted share were $0.29; adjusted earnings per diluted share were $0.65 The Company provides financial guidance for 2019 including total revenue in the range

PLAINSBORO, N.J., March 07, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will present at the following healthcare conference in March: On Tuesday, March 19, 2019 at 8:00 a.m.

PLAINSBORO, N.J. and TOKYO, March 14, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART ), a global leader in medical technology, announces the recent approval of DuraGen ® Dural Regeneration Matrix in Japan. DuraGen is the first and only non-autologous collagen

PLAINSBORO, N.J., April 09, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release first quarter 2019 financial results on Wednesday, April 24, 2019, prior to market open.

New innovations designed to help advance patient care PLAINSBORO, N.J., April 11, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, announced today that it will feature its latest innovations at the American Association

Reported revenues amounted to $359.7 million; organic revenues increased 3.1%  GAAP and adjusted earnings per diluted share were $0.38 and $0.65, respectively The Company reaffirms reported and organic revenue guidance for the full-year 2019 PLAINSBORO, N.J., April 24, 2019 (GLOBE NEWSWIRE) --

PLAINSBORO, N.J., April 30, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will present at the following healthcare conference in May: On Tuesday, May 14, 2019 at 4:20 p.m.

PLAINSBORO, N.J., May 23, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will present at the following healthcare conferences in June: On Wednesday, June 5, 2019 at 4:30 p.m.